About the Authors
- Theodora Szasz
-
* E-mail: iszasz@georgiahealth.edu
Affiliation Department of Physiology, Georgia Health Sciences University, Augusta, Georgia, United States of America
- Robert Patrick Davis
-
Affiliation Department of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan, United States of America
- Hannah S. Garver
-
Affiliation Department of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan, United States of America
- Robert J. Burnett
-
Affiliation Department of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan, United States of America
- Gregory D. Fink
-
Affiliation Department of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan, United States of America
- Stephanie W. Watts
-
Affiliation Department of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan, United States of America
Competing Interests
Financial support was provided by Takeda Pharmaceuticals U.S.A., Inc. in the form of a research grant (#MSA-FEB-134) and the study drug (febuxostat). Febuxostat is a product of Takeda Pharmaceuticals U.S.A., Inc. There are no further patents, products in development or marketed products to declare. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.
Author Contributions
Conceived and designed the experiments: TS GDF SWW. Performed the experiments: TS RPD HSG RJB SWW. Analyzed the data: TS RJB SWW. Contributed reagents/materials/analysis tools: GDF SWW. Wrote the paper: TS SWW.